(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | 192.5MM | +26% |
Gross Profit | 164.5MM | +28% |
Cost Of Revenue | 28.1MM | +15% |
Operating Income | 9.3MM | -169% |
Operating Expenses | 155.2MM | +9% |
Net Income | 14.8MM | -273% |
R&D | 31.1MM | +7% |
Amortization | 700K | -12% |
Interest Expense | 0 | - |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Thermo Fisher's (TMO) first-quarter 2024 revenues register year-over-year growth driven by new product launches.
Quest Diagnostics (DGX) continues its strong momentum of base business revenue growth in the first quarter of 2024.
Here is how Aldeyra Therapeutics, Inc. (ALDX) and Inspire Medical Systems (INSP) have performed compared to their sector so far this year.
The robust strength of Prestige Consumer's (PBH) diversified portfolio bodes well for investors.
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
Inspire (INSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Abbott (ABT) delivers double-digit organic sales growth in its underlying base business in the first quarter of 2024.
For many, the main point of investing in the stock market is to achieve spectacular returns. While not every stock...
UnitedHealth's (UNH) first-quarter results are likely to reflect growth in premium levels and service revenues.
UnitedHealth's (UNH) first-quarter results are expected to benefit from an increase in UnitedHealthcare's Community & State revenues and the number of people it served.